Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 1621 AL 1635

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study

Millar PR, Gordon BA, Luckett PH, Benzinger TLS, Cruchaga C, Fagan AM, Hassenstab JJ, Perrin RJ, Schindler SE, Allegri RF, Day GS, Farlow MR, Mori H, Nübling G; Dominantly Inherited Alzheimer Network; Bateman RJ, Morris JC, Ances BM.

Elife. 2023 Jan 6;12:e81869. doi: 10.7554/eLife.81869.

Shaping the risk for late-life neurodegenerative disease: A systematic review on prenatal risk factors for Alzheimer's disease-related volumetric brain biomarkers

Boots A, Wiegersma AM, Vali Y, van den Hof M, Langendam MW, Limpens J, Backhouse EV, Shenkin SD, Wardlaw JM, Roseboom TJ, de Rooij SR.

Neurosci Biobehav Rev. 2023 Mar;146:105019. doi: 10.1016/j.neubiorev.2022.105019. Epub 2023 Jan 3.

Association between anxiety symptoms and Alzheimer's disease biomarkers in cognitively healthy adults: A systematic review and meta-analysis

Demnitz-King H, Saba L, Lau Y, Munns L, Zabihi S, Schlosser M, Del-Pino-Casado R, Orgeta V, Marchant NL.

J Psychosom Res. 2023 Mar;166:111159. doi: 10.1016/j.jpsychores.2023.111159. Epub 2023 Jan 20.

Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer's Disease in China: A Cross-Sectional Observational Study

Wan K, Yin W, Tang Y, Zhu W, Wang Z, Zhou X, Zhang W, Zhang C, Yu X, Zhao W, Li C, Zhu X, Sun Z.

J Alzheimers Dis. 2023;92(1):81-93. doi: 10.3233/JAD-221100.

Challenges and opportunities of diagnostic markers of Alzheimer's disease based on structural magnetic resonance imaging

Hu X, Meier M, Pruessner J.

Brain Behav. 2023 Mar;13(3):e2925. doi: 10.1002/brb3.2925. Epub 2023 Feb 16.

Neuropsychiatric Symptoms and Commonly Used Biomarkers of Alzheimer's Disease: A Literature Review from a Machine Learning Perspective

Shah J, Rahman Siddiquee MM, Krell-Roesch J, Syrjanen JA, Kremers WK, Vassilaki M, Forzani E, Wu T, Geda YE.

J Alzheimers Dis. 2023;92(4):1131-1146. doi: 10.3233/JAD-221261.

Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts

Lantero-Rodriguez J, Vrillon A, Fernández-Lebrero A, Ortiz-Romero P, Snellman A, Montoliu-Gaya L, Brum WS, Cognat E, Dumurgier J, Puig-Pijoan A, Navalpotro-Gómez I, García-Escobar G, Karikari TK, Vanmechelen E, Ashton NJ, Zetterberg H, Suárez-Calvet M, Paquet C, Blennow K.

Alzheimers Res Ther. 2023 Mar 10;15(1):48. doi: 10.1186/s13195-023-01201-0.

Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease

Yu X, Shao K, Wan K, Li T, Li Y, Zhu X, Han Y.

Chin Med J (Engl). 2023 Mar 5;136(5):505-521. doi: 10.1097/CM9.0000000000002566.

Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications

Gonzalez-Ortiz F, Kac PR, Brum WS, Zetterberg H, Blennow K, Karikari TK.

Mol Neurodegener. 2023 Mar 16;18(1):18. doi: 10.1186/s13024-023-00605-8.

Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol

König A, Linz N, Baykara E, Tröger J, Ritchie C, Saunders S, Teipel S, Köhler S, Sánchez-Benavides G, Grau-Rivera O, Gispert JD, Palmqvist S, Tideman P, Hansson O.

J Prev Alzheimers Dis. 2023;10(2):314-321. doi: 10.14283/jpad.2023.11.

Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum

Kuhn E, Perrotin A, La Joie R, Touron E, Dautricourt S, Vanhoutte M, Vivien D, de La Sayette V, Chételat G; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2023 Jun 13;100(24):e2454-e2465. doi: 10.1212/WNL.0000000000207338. Epub 2023 Apr 21.

Methodological flaws in"diagnostic accuracy of blood biomarkers for Alzheimer's disease and amnestic mild cognitive impairment: A meta-analysis"

Hsu YP, Hsu CW, Chen LF, Liu YK.

Ageing Res Rev. 2023 Jul;88:101938. doi: 10.1016/j.arr.2023.101938. Epub 2023 Apr 23.

Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis

Donaghy PC, Carrarini C, Ferreira D, Habich A, Aarsland D, Babiloni C, Bayram E, Kane JP, Lewis SJ, Pilotto A, Thomas AJ, Bonanni L; Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment Lewy Body Dementias Prodromal Working Group.

Alzheimers Dement. 2023 Jul;19(7):3186-3202. doi: 10.1002/alz.13105. Epub 2023 Apr 24.

Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease

Lambert JC, Ramirez A, Grenier-Boley B, Bellenguez C.

Mol Psychiatry. 2023 Jul;28(7):2716-2727. doi: 10.1038/s41380-023-02076-1. Epub 2023 May 2.

Assessing adipokines as potential biomarkers of dementia, Alzheimer's disease, and mild cognitive impairment: A systematic review and meta-analysis

García-García I, Fernández-Andújar M, Narváez M, García-Casares N.

Obes Rev. 2023 Aug;24(8):e13573. doi: 10.1111/obr.13573. Epub 2023 May 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias